Development and external validation of prediction models for a trial-informed operational composite after stage 3 acute kidney injury

Development and external validation of prediction models for a trial-informed operational composite after stage 3 acute kidney injury. Download PDF Abstract Renal replacement therapy (RRT) is considered when severe acute kidney injury (AKI) is complicated by severe electrolyte disturbance, acid-base derangement, fluid overload with respiratory compromise, or azotaemia. Actual RRT initiation is influenced by clinician and centre practice.

We developed and externally validated machine-learning models to predict subsequent fulfilment of a trial-informed operational composite within 24–72 h after creatinine- or urine-output-defined stage 3 AKI. The prediction time was 24 h after stage 3 AKI onset. At this landmark, eligible patients remained alive in the ICU and had not received RRT or met any composite criterion.

Predictors were routinely collected during the first 24 h. The composite comprised potassium > 6.0 mmol/L; pH ≤ 7.20 with bicarbonate ≤ 12 mmol/L within ± 2 h; fluid balance > 10% of cleaned body weight with PaO₂/FiO₂ ≤200; or blood urea nitrogen > 112 mg/dL. MIMIC-IV included 2,457 patients (238 events, 9.7%) and eICU-CRD 3,228 (145 events, 4.5%).

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with qualified healthcare professionals for medical decisions and treatment options.